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A Shankar
Email: manjunath576117@yahoo.co.in

Abstract
Background: Psoriasis has been considered of late as dermatological disorder with systemic inflammation that
could contribute to various systemic events. There are studies that have demonstrated increased Serum uric acid
levels in patients with psoriasis and psoriatic arthritis. There have been no studies so far on Uric acid levels in
relation to psoriasis and metabolic syndrome (MetS). Objectives: The purpose of this study was to investigate
the possible presence of hyperuricemia in non-arthritic psoriasis and to analyze serum uric acid levels in psoriasis
patients with and without MetS and in controls with and without MetS. Uric acid levels were also correlated with
severity and duration of psoriasis. Materials and Methods: We performed a case control study on 100 psoriasis
patients, 39 with MetS and 61 without MetS and 100 controls, 22 with and 78 without MetS, matched for age
and sex. Serum uric acid levels were measured in all groups. Results: The overall serum uric acid levels were
significantly higher in psoriasis patients when compared to the controls (P = 0.001). A significant increase was also
observed in psoriasis patients with MetS than those without MetS in the same group (P = <0.001). Similar increase
was observed between those with MetS in the psoriasis and control groups (P = <0.001). Conclusion: Serum uric
acid should be monitored in patients with psoriasis. However, a prospective study is required in order to determine
if the prevention or treatment of hyperuricemia may affect the development of MetS or the course of psoriasis.
Key words: Psoriasis, serum uric acid, metabolic syndrome, duration, severity

Introduction
Psoriasis is a chronic, immune mediated
inflammatory
skin
disease
characterized
by epidermal hyper proliferation, impaired
differentiation
of
keratinocytes,
excessive
angiogenesis and immunological dysfunction1, 2.
The aetiology of psoriasis is complex; autoimmune

dysfunction is believed to play a significant role in its
basic pathophysiology. It is designated as a genetic,
systemic, inflammatory disorder of skin 3, 4. Although
conventionally, psoriasis has been considered a
dermatologic disease, modern day medical literature
is accumulating to support the statement that
psoriasis is actually a multisystem disease. It is
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associated with MetS, which includes obesity, raised
triglycerides, low high-density lipoprotein (HDL),
insulin resistance, and hypertension 4, 5. Uric acid
is a product of the metabolic breakdown of purine
nucleotides. High levels of uric acid are commonly
seen in patients with the MetS and its levels are
known to increase with the number of components
of this condition. Among the components of MetS,
elevated triglyceride has the most influence on serum
uric acid levels 6, 7. Numerous mechanisms, both
direct and indirect, explain the increased serum uric
acid levels with MetS due to which it is considered
a strong, independent predictor of incident MetS
among men and women 8, 9.
The association between serum uric acid levels with
psoriasis and psoriatic arthritis has been established
10, 11, 12
. Many studies have described the increased
levels of uric acid in MetS as a secondary occurrence;
however, some studies have reported that an elevated
uric acid level predicts the development of MetS per
se 13, 14. Serum uric acid levels are known to increase
with the increases in the duration and severity of
psoriasis and in psoriatic arthritis. Such elevations
positively correlated with Psoriasis Area and
Severity index (PASI), extent of skin involvement
and Body Mass Index (BMI) 15, 16.
There are no studies so far examining the relation
between uric acid levels, psoriasis, and MetS as per
our knowledge. Hence, we investigated the role
of uric acid in relation to psoriasis and MetS. In
addition, we evaluated the correlation among uric
acid levels in various groups of psoriasis patients
divided based on severity and duration.

Materials and methods
The study was conducted in the Department of
dermatology, Yenepoya Medical College hospital,
Yenepoya University, Deralakatte, Mangalore,
Karnataka, India after obtaining ethical clearance
from the University Ethics Committee.
Sampling: It was a hospital based case-control
study. Hundred psoriasis patients above the age of
eighteen years and hundred participants without
psoriasis (control) attending the department of
dermatology, Yenepoya Medical College Hospital,
Deralakatte; Mangalore, India were studied.
10
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Patients with acute febrile illness, active systemic
diseases/events such as arthritis, renal disease,
hepatic disease, malignancies, pregnancy etc., and
individuals with prior history of taking medications
for diabetes mellitus or dyslipidemia were excluded
from the study.
Clinical Assessment: Patients and controls willing
to participate in the study were included after taking
an informed consent. Detailed history was taken.
Clinical examination including general, systemic,
and dermatological examination was carried out.
A detailed history taking included duration of
the disease, severity, joint pain, smoking, alcohol
consumption, diet, presence of other systemic
illness, past intake of systemic agents for psoriasis
and concomitant intake of medicines for other
illnesses.
Duration and severity of psoriasis were recorded.
The severity of psoriasis was clinically assessed
by PASI score13. Patients were divided into two
groups as PASI ≤ 12 (mild to moderate) and PASI
>12 (severe) based on the severity17. Based on the
duration of the disease, patients were divided into
two groups as ≤ 2 years and > 2 years. Height,
weight, waist circumference, and blood pressure
were measured as a part of clinical examination.
The waist circumference was measured by placing
the measuring tape closely around the abdomen at
the level of the iliac crest.
Blood sampling: All patients and controls underwent
the following biochemical tests after overnight
fasting.
Assay: Serum fasting glucose levels was measured
by the hexokinase method, and lipid profile which
included total cholesterol, low density lipoprotein
(LDL), high density lipoprotein (HDL), triglyceride
levels and uric acid was measured by enzymatic
methods Vitros 5.1(J&J) analyzer.
MetS was diagnosed using the South Asian ModifiedNational Cholesterol Education Program Adult
Treatment Panel III (SAM-NCEP ATP III) criteria
17, 18
. As per the criteria, the patient was diagnosed as
having MetS if three or more of the following were
present. They are abdominal obesity (definition of
abdominal obesity was modified using Asia Pacific
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WHO guidelines as waist circumference ≥90 cm
for males and ≥80 cm for females), blood pressure
≥130/85 mmHg, fasting blood glucose ≥100 mg/
dl, hypertriglyceridemia ≥ 150 mg/dl, or low HDL
cholesterol (<40 mg/dl for males and <50 mg/dl for
females).
Statistical Analysis: SPSS (Statistical Package for
Social Studies), South Asia Pvt. Ltd. version 17.0
was used to carry out the analysis. The continuous
variables were expressed as mean and standard
deviation (SD). Student’s unpaired t-test was used
for the comparison of groups. ANOVA was used for
comparison between multiple groups. Post hoc test
was carried out to check multiple comparisons. P
value of less than 0.05 was considered significant.

Serum uric acid levels were compared among the
four groups i.e., psoriasis with MetS, psoriasis
without MetS, controls with MetS and controls
without MetS groups as presented in Table 2.
Serum uric acid levels were found to be significantly
higher in psoriasis patients with MetS when
compared with those patients without MetS (P
< 0.001), and when compared with controls with
MetS (P = 0.001). In both groups without MetS,
uric acid levels were higher in psoriasis group and
were statistically significant. Values were highest in
psoriasis patients with MetS and lowest in controls
without MetS as shown in Figure 1.

Results
The study included one hundred patients and one
hundred controls. These groups were matched for
age and gender. Thirty-seven patients had short
duration of the disease, i.e., less than two years;
sixty-three patients had the disease for more than
two years. Patients had mild to severe psoriasis with
PASI score ranging from 0.9 to 70.8. Forty-four
(44%) patients had mild to moderate psoriasis (PASI
≤ 12) and Fifty-six (56%) had severe psoriasis (PASI
>12).
Psoriasis patients were divided into two groups
based on the presence of MetS as per SAM NCEP
ATP III criteria. Out of 100 psoriasis patients, 39
had MetS. Similarly, the control group was also
divided into two groups based on the presence of
MetS. Out of the hundred controls, 22 subjects had
MetS.
The values of the serum uric acid levels for the
control and psoriasis patient groups were found as
presented in Table 1. Serum uric acid levels were
found to be significantly higher in psoriasis group
than in control group (p=0.001).
Table 1: Comparison of uric acid values between controls and
psoriasis patients’ groups

Uric acid (mg/dl)
Cases
Controls

Mean ± SD
6.26±1.9
5.48±1.25

*Confidence interval

CI*
5.88-6.63
5.23-5.74

p value
0.001

Figure 1: Mean uric acid values in all groups

`Serum uric acid levels and duration, and severity
of psoriasis
The values of the serum uric acid levels as compared
between the mild to moderate and severe psoriasis
patient groups are presented in Table 3. The mean
uric acid level was higher in the severe group but not
statistically significant. The values of the serum uric
acid levels as compared between the patients having
short duration of the disease, i.e., less than 2 years
and patients’ having the disease for more than 2 years
are presented in Table 4. Serum uric acid levels were
found to be significantly higher in psoriasis patients
having long duration of the disease (> 2 years).
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Table 2: Comparison of uric acid values among the groups
Uric acid(mg/dl)
Mean ± SD

Group 1 variables

Psoriasis with MetS**

7.33±2.35

Psoriasis without
MetS

5.57±1.11

Controls with MetS

7.12±0.89

Group 2 Variables

Uric acid(mg/dl)
Mean ± SD

CI*

p value

Psoriasis without MetS

5.57±1.11

5.28-5.85

< 0.001

Controls with MetS

7.12±0.89

6.72-7.52

< 0.001

Controls without MetS

4.99±0.87

4.79-5.20

< 0.001

Controls with MetS

7.12±0.89

6.72-7.52

< 0.001

Controls without MetS

4.99±0.87

4.79-5.20

< 0.001

Controls without MetS

4.99±0.87

4.79-5.20

< 0.001

Group 1: variables compared with group 2 variables*Confidence interval, **Metabolic syndrome
Table 3: Comparison of uric acid values between mild to
moderate psoriasis and severe psoriasis groups
Uric acid(mg/dl)

Mean ± SD

CI**

PASI* ≤ 12
6.14±2.04
(Mild to moderate)

5.52-6.71

PASI* >12
(Severe)

5.86-6.82

6.34±1.81

p value
0.612

*Psoriasis Area Severity Index, **Confidence interval

Table 4: Comparison of Uric acid values between psoriasis

patients having short duration (<2 years) and long duration (> 2
years) of the disease

Uric acid(mg/dl)

Mean ± SD

CI*

Duration of the
disease(<2years)

5.72±1.24

5.30-6.15

Duration of the
disease(>2years)
(Severe)

6.56±2.14

6.025-7.09

p value

0.035

*Confidence interval

Discussion
Similar to earlier studies, which have demonstrated
higher Uric acid levels in psoriasis patients, we
found significantly higher serum uric acid levels in
psoriasis patients when compared to controls10, 11.
However, a few other studies have demonstrated
conflicting results 14. Hyperuricemia in psoriasis
could be a result of accelerated epidermal turnover.
The psoriasis patients show marked improvements
when treated for their hyperuricemia19.
Hyperuricemia is a common finding among patients
with the MetS and is considered a predictor of MetS
development. Its presence could be an indication to
screen for and aggressively treat any accompanying
hypertension, dyslipidaemia or diabetes mellitus1, 20, 21.
12
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In our study, Serum uric acid levels were highest
in psoriasis patients with MetS and lowest in
controls without MetS suggesting that uric acid
could contribute to the MetS in psoriasis patients.
However, Serum uric acid levels were significantly
higher in psoriasis patients with MetS when
compared to controls with MetS, thus suggesting
a role in psoriasis irrespective of the presence of
MetS.
The studies have also demonstrated that an elevated
serum uric acid is positively correlated with PASI14.
Serum uric acid levels exacerbate with the increases
in severity and duration of psoriasis15. In our study,
we found no correlation between serum uric acid
levels and severity of psoriasis. Serum uric acid
levels were found to be significantly higher in
patients having long duration of the disease (>2
years). Serum uric acid levels are higher in psoriasis
patients irrespective of the severity of the disease.
However, Serum uric acid levels may exacerbate by
increasing the duration of the disease.

Conclusion
Our findings suggest that Serum uric acid should
be monitored in patients with psoriasis. However,
further studies are required to determine if the
prevention or treatment of hyperuricemia may
affect the course of psoriasis and the development
of MetS.
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